Chronic Lymphocytic Leukemia - CLL - Patients Reach Five-Year Survival Milestone After Receiving Campath Therapy.Chronic Lymphocytic Leukemia chronic lymphocytic leukemia n. Abbr. CLL Lymphocytic leukemia occurring mainly in older adults, characterized by slow onset and gradual progression of symptoms. (CLL CLL abbr. chronic lymphocytic leukemia CLL, n.pr See leukemia, chronic lymphocytic. CLL 1. Chronic lymphocytic leukemia 2. Cholesterol-lowering lipid ) is the most prevalent form of adult leukemia. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. a recent study, 84 percent of patients with CLL in whom all detectable traces of the disease were eliminated were still alive at least five years after receiving Campath (alemtuzumab) therapy. The study was published in the May issue of the Journal of Clinical Oncology The Journal of Clinical Oncology is a medical journal published by the American Society of Clinical Oncology. The Journal was founded in 1983 and publishes original research and review articles on topics relating to cancer. It is published 3 times a month. and represents a major step towards finding a cure for CLL. You can reach the story directly by going to http://www.newstream.com/home.aspx?story=30513 This multimedia news story is for free and unrestricted use on your news information site (and for print or broadcast too). Visit http://www.newstream.com to download video, audio, text, graphics and photos. If you have any questions about the story, or about Newstream.com, please write to us at info@newstream.com |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion